Quality of Nursing Care During The Covid-19 Pandemic

Sponsor
Tokat Gaziosmanpasa University (Other)
Overall Status
Completed
CT.gov ID
NCT05841602
Collaborator
(none)
128
1
5.9
21.6

Study Details

Study Description

Brief Summary

Enabling school-age children to evaluate the care they receive provides feedback on the quality of care by determining children's satisfaction with care, and gives important feedback on the quantity and quality of care. Evaluation of nursing care, emotions and behaviors from the perspective of children during the Covid-19 pandemic process will guide the improvement of the quality of care. As a result of the literature review on this subject, no research has been found, and it is thought that this research will contribute to the field. This research was conducted to evaluate nursing care and emotions from the perspective of hospitalized children during the Covid-19 pandemic process.

Condition or Disease Intervention/Treatment Phase
  • Other: descriptive

Study Design

Study Type:
Observational
Actual Enrollment :
128 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Quality of Nursing Care During The Covid-19 Pandemic From The Perspective Of Hospitalized Children: A Cross-Sectional Study
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Mar 1, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
study group

8-13 age group (N=128).

Other: descriptive
This research was conducted to evaluate nursing care from the perspective of hospitalized children during the Covid-19 pandemic process and to determine their feelings during this process.

Outcome Measures

Primary Outcome Measures

  1. The Scale Evaluation Quality of Care From Children's Point of View [4 month]

    The Scale Evaluation Quality of Care From Children's Point of View is a 5-point Likert-type scale (never = 1, rarely agree = 2, sometimes agree= 3, often agree = 4, always agree=5) involving 15 items, which was developed by Yilmaz and Ak (2018). The minimum score that can be obtained from the scale is 15 and the maximum score is 75.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The study included volunteer children who were hospitalized for at least 3 days in the

  • -- -pediatric clinic,

  • whose native language was Turkish,

  • between the ages of 8-13,

  • who did not have any visual, auditory or mental problems, and whose parents gave consent for the study.

Exclusion Criteria:
  • who fall outside the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tokat Gaziosmanpasa University Tokat Eyalet/Yerle┼čke Turkey 60200

Sponsors and Collaborators

  • Tokat Gaziosmanpasa University

Investigators

  • Study Chair: Mukaddes Demir Acar, Tokat Gaziosmanpasa University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mukaddes Demir Acar, Ass. Prof., Tokat Gaziosmanpasa University
ClinicalTrials.gov Identifier:
NCT05841602
Other Study ID Numbers:
  • MDEMIRACAR
First Posted:
May 3, 2023
Last Update Posted:
May 3, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 3, 2023